{"filing":{"accession_number":"0001279569-26-000865","cik":"0001683541","ticker":"ACB","company_name":"AURORA CANNABIS INC","form":"6-K","filing_date":"2026-09-09","report_date":"2026-09-09","primary_document":"aurora_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1683541/000127956926000865/aurora_6k.htm"},"events":[{"id":32194,"run_id":29576,"accession_number":"0001279569-26-000865","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Aurora Cannabis announces the appointment of Faris El Refaie as Executive Vice President, Global Commercial, effective September 28, 2026. This is a newly created executive role with responsibility for the company's global commercial function, medical cannabis market strategy, and international expansion across Canada, Europe, Australia, and New Zealand. The appointment of a seasoned biopharmaceutical executive to a senior leadership position overseeing global commercial operations is material to investors assessing the company's strategic direction and management capability.","company_name":"AURORA CANNABIS INC","ticker":"ACB","filing_date":"2026-09-09","form":"6-K","submitted_at":null,"items":[{"id":35307,"accession_number":"0001279569-26-000865","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Aurora Cannabis announces the appointment of Faris El Refaie as Executive Vice President, Global Commercial, effective September 28, 2026. This is a newly created executive role with responsibility for the company's global commercial function, medical cannabis market strategy, and international expansion across Canada, Europe, Australia, and New Zealand. The appointment of a seasoned biopharmaceutical executive to a senior leadership position overseeing global commercial operations is material to investors assessing the company's strategic direction and management capability.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-09T11:39:41.747641+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35307,"accession_number":"0001279569-26-000865","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Aurora Cannabis announces the appointment of Faris El Refaie as Executive Vice President, Global Commercial, effective September 28, 2026. This is a newly created executive role with responsibility for the company's global commercial function, medical cannabis market strategy, and international expansion across Canada, Europe, Australia, and New Zealand. The appointment of a seasoned biopharmaceutical executive to a senior leadership position overseeing global commercial operations is material to investors assessing the company's strategic direction and management capability.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-09T11:39:41.747641+00:00","company_name":"AURORA CANNABIS INC","ticker":"ACB","filing_date":"2026-09-09"}]}